Singapore markets closed

Omega Therapeutics, Inc. (OMGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.0700-0.1700 (-7.59%)
At close: 04:00PM EDT
2.1100 +0.04 (+1.93%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
4,938
3,094
2,073
144
0
-
Operating expenses
Research development
72,493
77,169
81,167
47,865
21,063
-
Selling general and administrative
27,339
26,186
23,672
16,603
6,236
-
Total operating expenses
99,832
103,355
104,839
66,176
28,645
-
Operating income or loss
-94,894
-100,261
-102,766
-66,032
-28,645
-
Interest expense
-
-
-
910
777
595
Total other income/expenses net
157
23
-157
-1,338
-25
-
Income before tax
-92,278
-97,428
-102,701
-68,280
-29,447
-
Income from continuing operations
-92,278
-97,428
-102,701
-68,280
-29,447
-
Net income
-92,278
-97,428
-102,701
-68,280
-29,447
-
Net income available to common shareholders
-92,278
-97,428
-102,701
-68,280
-29,447
-
Basic EPS
-2.08
-
-2.14
-3.05
-0.95
-0.69
Diluted EPS
-2.08
-
-2.14
-3.05
-0.95
-0.69
Basic average shares
52,225
-
47,881
22,404
31,126
25,912
Diluted average shares
52,225
-
47,881
22,404
31,126
25,912